PBIT of Pharmaceutical segment for June 17 quarter stood at Rs 24.59 crore, up by 34% YoY and that of Crop Protection products business stood at Rs 9.57 crore, down by 24% YoY.

Overall, OPM stood at 18.9% resulting in an OP of Rs 49.67 crore, up by 14% YoY basis.

Other income stood at Rs 1.58 crore up by 70%. Interest costs were lower by 11% to Rs 11.69 crore and thus PBDT was higher by 26% to Rs 39.56 crore. Depreciation was higher by 20% to Rs 21.26 crore thus resulting in a PBT of Rs 18.30 crore, up by 35% YoY. After paying total tax of Rs 4.98 crore up by 148% YoY, PAT for June 17 quarter stood at Rs 13.32 crore, up by 15% YoY.

Performance for the 12 months ended Mar'17

Net sales for 12 months ended Mar'17 of Hikal stood at Rs 1013.94 crore, up by about 10% YoY. Pharmaceutical segment sales was up by 6% to Rs 605.21 crore and that of Crop protection segment was up by 15% to Rs 408.73 crore.

PBIT of Pharmaceutical segment for 12 months ended Mar'17 stood at Rs 78.66 crore, down by 2% YoY and that of Crop Protection products business stood at Rs 75.45 crore, up by 38% YoY.

Overall, OPM stood at 19.5% resulting in an OP of Rs 197.42 crore, up by 9% YoY basis.

Other income stood at Rs 3.44 crore up by 87%. Interest costs were lower by 22% to Rs 48.77 crore thus PBDT was higher by 26% to Rs 152.09 crore. Depreciation was up by 3% to Rs 69.14 crore. Thus, PBT was higher by 56% to Rs 82.95 crore. After paying total tax of Rs 16.15 crore including deferred tax, up by 35% YoY, PAT for 12 months ended Mar'17 stood at Rs 66.80 crore, up by 62% YoY.